Langley, RE; Gilbert, DC; Duong, T; Clarke, NW; Nankivell, M; Rosen, SD; Mangar, S; ... Parmar, M; + view all Langley, RE; Gilbert, DC; Duong, T; Clarke, NW; Nankivell, M; Rosen, SD; Mangar, S; Macnair, A; Sundaram, SK; Laniado, ME; Dixit, S; Madaan, S; Manetta, C; Pope, A; Scrase, CD; Mckay, S; Muazzam, IA; Collins, GN; Worlding, J; Williams, ST; Paez, E; Robinson, A; McFarlane, J; Deighan, JV; Marshall, J; Forcat, S; Weiss, M; Kockelbergh, R; Alhasso, A; Kynaston, H; Parmar, M; - view fewer (2021) Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme. The Lancet , 397 (10274) pp. 581-591. 10.1016/s0140-6736(21)00100-8.